BC
KDNY

Birchview Capital’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Birchview Capital’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15,000
Closed -$576K – 53
2023
Q2 		$576K Hold
15,000
– – 0.43% 35
2023
Q1 		$347K Buy
+15,000
New +$347K 0.27% 38